Cargando…

EZH2 enhances the invasive capability of renal cell carcinoma cells via activation of STAT3

The enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2) gene has been recognized to be a proto-oncogene and to be linked to human malignancies. However, the additional functions of EZH2 in renal cell carcinoma (RCC) are not completely understood. In the present study, a possible role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Dong, Yang, Xiao-Jie, Luo, Qi-Dong, Fu, De-Lai, Li, Hong-Liang, Li, He-Cheng, Zhang, Peng, Chong, Tie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802166/ https://www.ncbi.nlm.nih.gov/pubmed/29286132 http://dx.doi.org/10.3892/mmr.2017.8363

Ejemplares similares

EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells
por: Zheng, Min, et al.
Publicado: (2019)

Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion
por: Wang, Yu, et al.
Publicado: (2018)

Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion
por: Wang, Yu, et al.
Publicado: (2023)

Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E
por: Li, Gang, et al.
Publicado: (2017)

EZH2-inhibitor DZNep enhances apoptosis of renal tubular epithelial cells in presence and absence of cisplatin
por: Chen, Si-qi, et al.
Publicado: (2020)

EZH2 Promotes T Follicular Helper Cell Differentiation Through Enhancing STAT3 Phosphorylation in Patients With Primary Sjögren’s Syndrome
por: He, Chengmei, et al.
Publicado: (2022)

Long noncoding RNA SNHG6 silencing sensitized esophageal cancer cells to 5-FU via EZH2/STAT pathway
por: Tan, Ran, et al.
Publicado: (2023)

Inhibition of EZH2 exerts antitumorigenic effects in renal cell carcinoma via LATS1
por: Hong, Seong Hwi, et al.
Publicado: (2023)

EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells
por: Mu, Zhaomei, et al.
Publicado: (2013)

Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3‐, STAT3‐ and β‐catenin‐mediated epithelial‐mesenchymal transition
por: Xu, Shen, et al.
Publicado: (2020)

Solamargine induces apoptosis of human renal carcinoma cells via downregulating phosphorylated STAT3 expression
por: Huang, Shuaishuai, et al.
Publicado: (2023)

EZH2 inhibition suppresses bladder cancer cell growth and metastasis via the JAK2/STAT3 signaling pathway
por: Chen, Zhiyuan, et al.
Publicado: (2019)

EZH2 Exacerbates Breast Cancer by Methylating and Activating STAT3 Directly
por: Zhao, Yi, et al.
Publicado: (2021)

miR-101-3p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2
por: Dong, Yunze, et al.
Publicado: (2021)

Baicalein Inhibits the Invasion and Metastatic Capabilities of Hepatocellular Carcinoma Cells via Down-Regulation of the ERK Pathway
por: Chen, Kunlun, et al.
Publicado: (2013)

HIF1α epigenetically repressed macrophages via CRISPR/Cas9-EZH2 system for enhanced cancer immunotherapy
por: Dong, Yan, et al.
Publicado: (2021)

Expression of CK19, CD105 and CD146 are associated with early metastasis in patients with renal cell carcinoma
por: Yang, Xiaojie, et al.
Publicado: (2018)

EZH2 enhances expression of CCL5 to promote recruitment of macrophages and invasion in lung cancer
por: Xia, Lilong, et al.
Publicado: (2020)

miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2
por: YU, LI, et al.
Publicado: (2013)

STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer
por: Pan, Yuan-Ming, et al.
Publicado: (2016)

Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma
por: Zhong, Binlong, et al.
Publicado: (2019)

CRACD loss promotes small cell lung cancer tumorigenesis via EZH2-mediated immune evasion
por: Zhang, Shengzhe, et al.
Publicado: (2023)

Expression of EZH2 in endometrial carcinoma and its effects on proliferation and invasion of endometrial carcinoma cells
por: Gu, Yuting, et al.
Publicado: (2017)

LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
por: Luo, Jie, et al.
Publicado: (2019)

Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
por: Zhang, Qi, et al.
Publicado: (2017)

Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2
por: Guo, Jianping, et al.
Publicado: (2018)

Downregulation of histone-lysine N-methyltransferase EZH2 inhibits cell viability and enhances chemosensitivity in lung cancer cells
por: Cao, Ziyang, et al.
Publicado: (2021)

Inhibition of GSK 3β Activity Is Associated with Excessive EZH2 Expression and Enhanced Tumour Invasion in Nasopharyngeal Carcinoma
por: Ma, Renqiang, et al.
Publicado: (2013)

Melatonin sensitizes esophageal cancer cells to 5-fluorouracil via promotion of apoptosis by regulating EZH2 expression
por: Zhang, Mengti, et al.
Publicado: (2021)

Long noncoding RNA XIST promotes malignancies of esophageal squamous cell carcinoma via regulation of miR-101/EZH2
por: Wu, Xiaoliang, et al.
Publicado: (2017)

Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling
por: Xu, Bao-Qing, et al.
Publicado: (2016)

Epigenetic repression of the Igk locus by STAT5-mediated Ezh2 recruitment
por: Mandal, Malay, et al.
Publicado: (2011)

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
por: Wagener, Nina, et al.
Publicado: (2010)

Prognostic Value of EZH2 Expression and Activity in Renal Cell Carcinoma: A Prospective Study
por: Liu, Li, et al.
Publicado: (2013)

miR-125a restrains cell migration and invasion by targeting STAT3 in gastric cancer cells
por: Yang, Liu, et al.
Publicado: (2018)

DLGAP5 Regulates the Proliferation, Migration, Invasion, and Cell Cycle of Breast Cancer Cells via the JAK2/STAT3 Signaling Axis
por: Li, Yujie, et al.
Publicado: (2023)

Interleukin-22 Promotes Osteosarcoma Cell Proliferation and Invasion via STAT3 Activation
por: Li, Panpan, et al.
Publicado: (2018)

MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3
por: Wang, Jinpeng, et al.
Publicado: (2020)

ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma
por: Lu, Jun, et al.
Publicado: (2020)

Regulation of T Cell Differentiation and Function by EZH2
por: Karantanos, Theodoros, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hmg3m897aj6eetg517fg5bls79